Cite
HARVARD Citation
Karpova, D. et al. (2017). Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers—results of a dose escalation trial. Journal of translational medicine. 15 (1), pp. 1-12. [Online].